EXPRESSION OF ARGYROPHILIC NUCLEOLAR ORGANIZING REGION COUNTS AND PROLIFERATING CELL NUCLEAR ANTIGEN IN EPITHELIAL ODONTOGENIC TUMORS

Document Type : Original Article

Authors

1 -Instructor at Oral Pathology Department, Faculty of Oral and Dental Medicine, South Valley University

2 Professor Oral Pathology Department, Faculty of Dentistry, Alexandria University.

3 Professor Cranio Maxillofacial and Plastic Surgery, Faculty of Dentistry, Alexandria University.

Abstract

INTRODUCTION: Odontogenic tumors are diverse groups of lesions derived from odontogenic tissues. Clinical behavior of these lesions varies widely, ranging from benign to malignant with differences in recurrence rate and growth pattern. A better understanding of the underlying molecular mechanisms will help to predict the course of odontogenic tumors and lead to the development of new therapeutic applications. Nucleolar organizer regions (NORs) are loops of DNA that codify the ribosomal RNA and are considered important for protein synthesis. The NORs stained histochemicaly by silver are named argyrophilic nucleolar organizer regions (AgNOR). Quantification of AgNOR represents a valuable parameter of cell kinetics and therefore cell proliferation. The number of AgNOR sites in malignant cells is significantly greater than those in their normal or benign counterparts. Proliferating cell nuclear antigen (PCNA) is a useful marker of cellular proliferation and DNA replication. Malignant tissue is characterized by an uncoordinated proliferating cell nuclear antigen (PCNA). OBJECTIVES: To evaluate the cell proliferation rate using the expression of Argyrophilic Organizing Region counts and Proliferating Cell Nuclear Antigen in epithelial odontogenic tumors and to assess the usefulness of AgNOR and PCNA as markers in malignant potential of epithelial odontogenic tumors. MATERIALS AND METHODS: This study was done on 45 surgical specimens of epithelial odontogenic tumors and one control specimen from normal tooth germ.The tissue biopsies were processed and paraffin sections were prepared. Hematoxylin and eosin-stained sections were examined for diagnosis. Other sections were subjected to AgNORhistochemical technique and immunohistochemical staining for PCNA. Immunohistochemical staining was performed using a Labeled Strept-Avidin Biotin complex method (LSAB). RESULTS: The mean AgNOR count of tooth germ was 1.21 and the benign odontogenic tumors was 1.862.The highest AgNOR count was recorded in Ameloblastic carcinoma and lowest was seen in adenomatoid odontogenic tumor. Statistically significant difference in AgNOR counts of ameloblastoma and adenomatoid odontogenic tumor, ameloblastoma and calcifying epithelial odontogenic tumor, benign odontogenic tumors and ameloblastic carcinoma were seen. AgNORs in ameloblastic carcinoma were more in number and more widely distributed.The highest mean value of PCNA-positive cell percentage was demonstrated in ameloblastic carcinoma followed by ameloblastoma. A significant difference was noted when the PCNA value of ameloblastoma was compared with that of ameloblastic carcinoma. CONCLUSIONS: AgNOR technique may be considered a good indicator of cell proliferation in epithelial odontogenic tumors.The PCNA expression, along with the clinical features, can predict the aggressiveness, chances of recurrence and malignant potential of these tumors.

Keywords

Main Subjects

References

  1. Regezi JA, Scuibba AJ, Jordan RC. Oral Pathology, Clinical – Correlations.5th ed. Philadelphia: WB Saunders; 2003. 261-81.
  2. Barnes L, Eveson JW, Reichart P, Sidransky D. Pathology and Genetics of Head and Neck Tumours. Lyon: IARC Press; 2005. 284-327.
  3. Neville BW, Damm DD, Allen CM, Bouquot JE. A Textbook of Oral and Maxillofacial Pathology. 3rd ed. St. Louis: WM Saunders Co.; 2009. 701-31.
  4. Reichart PA, Philipsen HP. Odontogenic Tumors and Allied Lesions. London: Quintessence Publishing Co. Ltd.; 2004.
  5. Hernandez-Verdun D. The nucleolus: a model for the organization of nuclear functions. Histochem Cell Biol. 2006;126:135-48.
  6. Trere D. AgNOR staining and quantification. Micron. 2000;31:127-31.
  7. Eroz R, Unluhizarci K, Cucer N, Ozturk F. The Value OfArgyrophilicNucleolarOrganising Region Protein Determinations in Non-Diagnostic Fine Needle Aspiration Samples (Due To Insufficient Cell Groups) of Thyroid Nodules. Anal Quant CytopatholHistpathol. 2013;35:226- 31.
  8. Oktay M, Eroz R, Oktay NA, Erdem H, Başar F, Akyol L, et al. Argyrophilic nucleolar organizing region associated protein synthesis for cytologic discrimination of follicular thyroid lesions. Biotech Histochem. 2015;90:179-83.
  9. Eroz R, Okur M, Ozkan A, Berik O, Gunes C. Does higher NORsexpression affect the developmental stages of down syndrome infants? Genet Couns. 2012;23:249-53.
  10. Smith R, Crocker J. Evaluation of nucleolar organizer region-associatedproteins in breast malignancy. Histopathology. 1988;12:113-25.
  11. Hanemann JA, Miyazawa M, Souza MS. Histologic grading and nucleolar organizer regions in oral squamous cell carcinomas. J Appl Oral Sci. 2011;19:280-5.
  12. Alaeddini M, Khalili M, Tirgari F, Etemad-Moghadam S. Argyrophilic proteins of nucleolar organizer regions (AgNORs) in salivary gland mucoepidermoid carcinoma and its relation to histological grade. Oral Surg Oral Med Oral Pathol Oral RadiolEndod. 2008;6:758-62.
  13. Selvi B, Demirtas H, Eroz R, Imamoglu N. Investigation of the age dependent AgNOR protein level in buccal epithelial cells of healthy individuals. Aging ClinExp Res. 2015;201- 8.
  14. Colakoglu S, Saritas A, Eroz R, Oktay M, Yaykasli KO, Akoz A, et al. Is one-time carbon monoxide intoxication harmless?Evaluation by argyrophilic nucleolar-organizing regions staining method.Hum ExpToxicol. 2015;34:24-31.
  15. Kandis H, Afacan MA, Eroz R, Colakoglu S, Bayramoglu A, Oktay M, et al. Can argyrophilic nucleolar organizing region-associated protein amount be used for the detection of cardiac damage? Hum ExpToxicol. 2015;35:1-9.
  16. doCarmo MA, Silva EC. Argyrophilic nucleolar organizer regions (AgNORs) in ameloblastomasand adenomatoidodontogenictumours (AOTs). J Oral Pathol Med. 1998;27:153-6.
  17. Coleman HG, Altini M, Groeneveld HT. Nucleolar organizer regions (AgNORs) in odontogenic cysts andameloblastomas. J Oral Pathol Med. 1996;25:436-40.
  18. Kelman Z. PCNA: Structure, functions and interactions. Oncogene. 1997;14:629-40.
  19. Giovanni M, Hubscher U. Proliferating cell nuclear antigen (PCNA); a dancer with many partner. J Cell Sci. 2003;116:3051-60.
  20. Tsai ST, Jin YT. Proliferating cell nuclear antigen [PCNAI expression in oral squamous cell carcinomas. J Oral Pathol Med. 1995;24:313-5.
  21. Barboza CA, Pereira Pinto L, Freitas Rde A, Costa Ade L, Souza LB. Proliferating cell nuclearantigen (PCNA) and p53 protein expression in ameloblastoma and adenomatoid odontogenic tumor. Braz Dent J 2005;16:56-61.
  22. Lee JJ, Kuo MY, Cheng SJ, Chiang CP, Jeng JH, Chang HH, et al. Higher expressions of p53 and proliferating cell nuclear antigen (PCNA) in atrophic oral lichen planus and patients with areca quid chewing. Oral Surg Oral Med Oral Pathol Oral RadiolEndod. 2005;99:471-8.
  23. Ploton D, Menager M, Jeannesson P, Himber G, Piegeon F,AdnetJJ. Improvement in the staining and visualization of theargyrophilicproteins of the nucleolar organizer regions at theoptical level.Histochem J. 1986;18:5-14.
  24. Rosa LE, Jaeger MM, Jaeger RG. Morphometric study of nucleolar organizer regions in ameloblastoma and basal cell carcinoma. Oral Oncol. 1997;33:209-14.
  25. Santos AC, Chaves Tarquinio SB, Riet Correa Rivero E, Maria Aver Araujo L, Lorio Krause C. Quantitative AgNORs Study in ameloblastoma. Rev OdontolCienc. 2009;24:10-4.
  26. Selvi F, Tekkesin MS, Cakarer S, Isler SC, Keskin C. Keratocystic odontogenic tumors: Predictive factors of recurrence by Ki-67 and AgNOR labelling. Int J Med Sci. 2012;9:262-8.
  27. Do Carmo MA, Silva EC. Argyrophilic nucleolar organizer regions in ameloblastomas and adenomatoidodontogenic tumour (AOTs). J Oral Pathol Med. 1998;27:153-6.
  28. Kim J, Yook JI. Immunohistochemical study on proliferating cell nuclear antigen expression in ameloblastomas. Eur J Cancer B Oral Oncol. 1994;30:126- 31.
  29. Setsuko H, Masanobu S, Yaeko N, Hiroki M, Keigo K. An autopsy case of Malignantameloblastoma in maxilla: A case study. Oral Med Pathol. 1999;4:39-43.
  30. El Deeb A, Moustafa WA. Expression of cell proliferation markers (PCNAand AGNOR) inodontogenic cysts and ameloblastoma Official Journal of the Egyptian Dental Association; 2003.
  31. Funaoka K, Arisue M, Kobayashi I, Iizuka T, Kohgo T, Amemiya A,et al. Immunohistochemical Detection of Proliferating Cell Nuclear Antigen (PCNA) in 23 Cases of Ameloblastoma. Oral OncolEur J Cancer. 1996;32:328-32.
  32. Maya R, Sekar B, Murali S. Comparative evaluation of expression of proliferating cell nuclear antigen in variants of ameloblastoma and ameloblastic carcinoma. Indian J Dent Res. 2012;23:15-9.
  33. Meer S, Galpin JS, Altini M, Coleman H, Ali H. PCNA and Ki 67immuno reactivity in ameloblastomas. Oral Surg Oral Med Oral Pathol Oral RadiolEndod. 2003;95:213-21.

Files

Share

How to cite

Statistics